Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea

Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea

ObjectiveCognitive impairment is a common comorbidity in patients with obstructive sleep apnea (OSA) that leads to poor quality of life and a heavier medical burden. However, the assessment and longitudinal tracking of cognitive impairment in OSA is challenging. This study aimed to examine the alter...

Full description

Bibliographic Details
Main Authors: Xu Jiahuan, Zou Ying, Jin Hongyu, Wei Zhijing, Guan Shibo, Deng Chengyue, Fu Liangyu, Liu Fan, Wang Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
obstructive sleep apnea
mild cognitive impairment
soluble triggering receptor expressed on myeloid cells 2
serum
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.843828/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.843828/full

Similar Items